Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1108712

	registered interest
	date	01/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Skin Diseases: Prescriptions
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that the prescribing practices of Clinical Commissioning Groups follows the appropriate clinical guidelines set by NICE or NHS England on the use of emollients for patients with inflammatory skin conditions.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	239233
	answer	answer is ministerial correction date of answer 05/04/2019 answer text <p>The Department and NHS England expects clinical commissioning groups (CCGs) to take both NHS England and National Institute for Health and Care Excellence guidance into account in formulating local polices, and for prescribers to reflect local policies in their prescribing practice.</p><p> </p><p>In March 2018, CCG guidance was published on conditions for which over the counter items should not be routinely prescribed in primary care. This covers 35 minor conditions, including recommendations on the use of emollients for self-care of mild dry skin. The recommendation in this guidance only applies to those with mild dry skin or mild irritant dermatitis. If CCGs have implemented the guidance as intended, patients with moderate to severe eczema will still be able to receive their emollients on prescription as it is a chronic condition.</p><p> </p><p>NHS England has also recently run a consultation on ‘Items which should not routinely be prescribed in primary care: an update and a consultation on further guidance for clinical commissioning groups (CCGs)’. This included proposals around the proscribing of emollient bath and shower preparations (it did not cover all emollients, which come in a range of other formulations).</p><p> </p><p>Variation of prescribing of emollient bath and shower preparations was reviewed and published as part of the consultation undertaken from 28 November 2018 – 28 February 2019. Details of this are available in the consultation document at the following link:</p><p> </p><p><a href="https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf" target="_blank">https://www.engage.england.nhs.uk/consultation/items-routinely-prescribed-update/user_uploads/low-priority-prescribing-consultation-guidance.pdf</a></p><p> </p><p>NHS England is currently taking account of all consultation responses and updated CCG guidance is due to be published in the summer of 2019.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 238640 question first answered 05/04/2019 11:04:45 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4126 label Biography information for Mary Glindon

1587262

	registered interest
	date	20/02/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, To ask the Secretary of State for Health and Social Care, with reference to his Written Statement of 24 January on Government Action on Major Conditions and Diseases, HCWS514, what engagement his Department plans to have with the relevant cancer-related stakeholders on the Major Conditions Strategy.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	148607
	answer	answer is ministerial correction date of answer 01/03/2023 answer text <p>The Major Conditions Strategy will look at cancer, covering the patient pathway from prevention, through treatment, to follow-up care. The strategy will look at a wide range of interventions and enablers to improve outcomes and experience for cancer patients.</p><p>The Major Conditions Strategy will draw on previous work on cancer, including over 5,000 submissions provided to the Department as part of our Call for Evidence last year.  We will continue to work closely with stakeholders, citizens, and the National Health Service in coming weeks to identify actions for the strategy that will have the most impact.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately grouped question UIN 148606 question first answered 01/03/2023 11:13:43 answering member 4527 label Biography information for Helen Whately
	tabling member	4126 label Biography information for Mary Glindon

1675139

	registered interest
	date	04/12/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Electronic Cigarettes and Tobacco: Regulation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, draft Tobacco and Vapes Bill whether her Department has made an assessment of the potential impact of the vaping proposals contained in that consultation on smoking cessation.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	4975
	answer	answer is ministerial correction date of answer 11/12/2023 answer text <p>Smoking is responsible for around 80,000 deaths a year in the United Kingdom and causes around one in four cancer deaths in the UK. It also costs our country £17 billion a year and puts a huge burden on the National Health Service.</p><p>Vaping is rightly used by adults as a tool to quit smoking. They are substantially less harmful than cigarettes. However, the Government is concerned about the worrying rise in vaping among children, with youth vaping tripling in the last three years and one in five children having now used a vape.</p><p>This is why the Government is planning to create a smokefree generation by bringing forward legislation so that children turning 14 years old or younger this year will never be legally sold tobacco products, and further crack down on youth vaping by consulting on measures to reduce the appeal and availability of vapes to children.</p><p>We will publish our Impact Assessment shortly.</p> answering member constituency South Northamptonshire answering member printed Andrea Leadsom grouped question UIN 4973 question first answered 11/12/2023 17:17:32 answering member 4117 label Biography information for Andrea Leadsom
	tabling member	4126 label Biography information for Mary Glindon

1198006

	registered interest
	date	01/06/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Obesity
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how admissions are coded in hospitals for obesity; and if he will make a statement.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	51969
	answer	answer is ministerial correction date of answer 08/06/2020 answer text <p>Through the three chapters of ‘Childhood obesity: a plan for action’ we are bringing forward a wide range of measures to reduce the prevalence of children who are obese. We have seen important successes including the average sugar content of drinks subject to the soft drinks industry levy decreasing by 28.8% between 2015 and 2018, and significant investment being made in schools to promote physical activity and healthy eating. Many of the measures in the plan will have an impact on reducing obesity across all age groups.</p><p>Unicef’s ‘State of the World's Children’ report, published in October 2019, recognised that “the United Kingdom is paving the way to ensure that all children grow up in a healthy food environment”. The Unicef report is available at the following link:</p><p><a href="http://www.unicef.org/media/61356/file/SOWC-2019.pdf" target="_blank">www.unicef.org/media/61356/file/SOWC-2019.pdf</a></p><p>NHS Digital has advised that the Hospital Episodes Statistics uses World Health Organization International Classification of Diseases v.10 (ICD-10) to record the main diagnosis and any secondary co-morbidities. Within ICD-10 obesity is assigned as code E66 and this will be recorded on any episode of care where a clinical diagnosis of obesity has been made. The NHS Digital coding standard DCS.IV.3: Obesity (E66) states: Codes in category E66 Obesity must only be coded when a diagnosis of obesity is recorded in the medical record. Where body mass index (BMI) has been recorded in the medical record, this must not be used to assign a code from category E66.- Obesity. A clinical coder must always refer to the responsible consultant to confirm the clinical significance of a test result, for example BMI reading and/or relationship to a specific condition.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 51965 question first answered 08/06/2020 17:29:54 answering member 4380 label Biography information for Jo Churchill previous answer version 25914 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1299662

	registered interest
	date	04/03/2021
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Neuromuscular Disorders: Mental Health Services
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Improving Access to Psychological Therapies (IAPT) Long Term Condition services have been commissioned for people with (a) Parkinson's and (b) neurological conditions.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	163224
	answer	answer is ministerial correction date of answer 12/03/2021 answer text <p>No Improving Access to Psychological Therapies for Long Term Condition services have been commissioned specifically for people with Parkinson’s or neurological conditions.</p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 12/03/2021 15:08:03 answering member 1481 label Biography information for Ms Nadine Dorries
	tabling member	4126 label Biography information for Mary Glindon

1143007

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Parkinson's Disease: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Medicines Usage Reviews have been undertaken for people with Parkinson's in each year since their introduction.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284564
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>Since 2014, community pharmacy contractors have been required to conduct 70% of the Medicines Use Reviews (MURs) that they undertake on the following target groups and data is collected accordingly:</p><p>- Patients taking high-risk medicines (Non-steroidal anti-inflammatory drugs, anticoagulants, antiplatelets and diuretics);</p><p>- Patients recently discharged from hospital;</p><p>- Patients prescribed a respiratory drug, as specified; and</p><p>- Patients regularly prescribed four or more medicines, at least one of which is for a risk of cardiovascular disease, as specified.</p><p>Specific data is not collected on the remaining 30% and so it is not possible to say how many people taking medicines for Parkinson’s disease have received an MUR.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:14:49 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1143006

	registered interest
	date	02/09/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many Medicines Usage Reviews have taken place in each year since their introduction.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	284562
	answer	answer is ministerial correction date of answer 09/09/2019 answer text <p>This data has been extracted from the relevant editions of the National Statistics: ‘General Pharmaceutical Services’ for England, which is published on an annual basis by NHS Digital and compares a rolling 10 years data:</p><p> </p><p>2005/06: 148,195</p><p>2006/07: 559,315</p><p>2007/08: 951,358</p><p>2008/09: 1,397,319</p><p>2009/10: 1,707,139</p><p>2010/11: 2,108,604</p><p>2011/12: 2,434,128</p><p>2012/13: 2,820,415</p><p>2013/14: 3,081,108</p><p>2014/15: 3,183,094</p><p>2015/16: 3,313,309</p><p>2016/17: 3,368,005</p><p>2017/18: 3,381,441</p><p>2018/19: Not yet published</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 09/09/2019 15:17:11 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1223846

	registered interest
	date	13/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people have had to pay for an additional prescription as a result of their medication being recalled as a result of safety concerns in each year since 2015.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	72911
	answer	answer is ministerial correction date of answer 03/08/2020 answer text <p>If a prescription item is recalled, the patient is issued with a new prescription for an alternative product which will then be dispensed as a separate item. The prescriptions data systems are unable to identify this as a replacement product, therefore this information is not held centrally.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 03/08/2020 11:42:28 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1223852

	registered interest
	date	13/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people paid for a prescription between (a) January 2019 and June 2019 and (2) January 2020 and June 2020.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	72916
	answer	answer is ministerial correction date of answer 03/08/2020 answer text <p>This information is not collected centrally.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 03/08/2020 12:23:58 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon

1223847

	registered interest
	date	13/07/2020
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many people paid for a prescription in each year since 2015.
	tabling member constituency	North Tyneside
	tabling member printed	Mary Glindon
	uin	72912
	answer	answer is ministerial correction date of answer 03/08/2020 answer text <p>Data on prescriptions dispensed in the community is collected by the number of items, or the cost. Data is not held about the number of people who obtain a prescription.</p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 03/08/2020 11:45:46 answering member 4380 label Biography information for Jo Churchill
	tabling member	4126 label Biography information for Mary Glindon